Abbott Cardiovascular ✓

@AbbottCardio · Abbott Park, IL · joined 05 Apr 2013

We’re leading the way in heart and vascular health. Committed to #cardiovascular care. Proud member of #CardioTwitter. ToU: https://t.co/jHiC9I2B9d

16 921Followers

137Following

5 892Posts total

4.5KViews on collected posts

Son gönderiler

Abbott Cardiovascular ✓@AbbottCardio11 Sep

What can the latest INTERMACS data tell us about #LVAD utilization in older and underserved populations? Hear Dr. Aditi Nayak share insights on what’s ahead for advanced #HeartFailure care. Watch the full video: https://t.co/jtjuEtoWi5 US Safety Info: https://t.co/b3hCeecXy

1:06

807 views · 2 likes · 2 reposts · 0 replies Open on X →

Abbott Cardiovascular ✓@AbbottCardio11 Sep

NEW GUIDE-HF insights! A secondary analysis of #HeartFailure patients implanted with our #CardioMEMS HF System found that initiating angiotensin receptor-neprilysin inhibitors (ARNis) or mineralocorticoid receptor antagonists (MRAs) was associated with measurable, early https://

793 views · 3 likes · 0 reposts · 0 replies Open on X →

Abbott Cardiovascular ✓@AbbottCardio10 Sep

How has the legacy of the #HeartMate3 shaped the future of #LVAD therapy? Explore how evolving clinical data shows our HeartMate 3 as a trusted therapy that gives #HeartFailure patients more options, from prolongation of life, potential for recovery, and more in our upcoming htt

831 views · 1 likes · 0 reposts · 0 replies Open on X →

Abbott Cardiovascular ✓@AbbottCardio10 Sep

📰 BREAKING: our #TactiFlex Duo Ablation Catheter, Sensor Enabled is now approved for use in the US! Designed to deliver #PFA therapy, RF energy, or a combination of both, this catheter enables physicians to tailor treatment to the unique needs of each patient. Read the press h

0:22

1.2K views · 10 likes · 2 reposts · 0 replies Open on X →

Abbott Cardiovascular ✓@AbbottCardio10 Sep

Plaque matters when assessing #CarotidArteryDisease. Our CREST-2 + XACT webinar explores plaque morphology as a predictor of procedural complexity and patient risk, along with CREST-2 insights and real-world experiences with our #XACT Carotid Stent System. Watch now: https://t.

1:06

877 views · 4 likes · 1 reposts · 0 replies Open on X →

Aynı büyüklükteki hesaplara karşı

Son 90 güne ait 5 gönderi, 10K–100K takipçi aralığıyla yan yana. geniş kitleye gösteriliyor, ama izleyenlerin azı tepki veriyor.

Medyan görüntülenme831bu hesap1 01410K–100K için medyan

Erişim, %4.91%bu hesap3.74%10K–100K için medyan

Etkileşim, %0.50%bu hesap1.68%10K–100K için medyan

Ölçüt	Bu hesap	10K–100K için medyan	Oran
Gönderi başına medyan görüntülenme	831	1 014	0.82×
Erişim (görüntülenme ÷ takipçi)	4.91%	3.74%	1.31×
Etkileşim oranı	0.50%	1.68%	0.29×

Bu aralıktaki diğer hesaplar → Başka bir hesapla karşılaştır → Bu kıyas değerleri nasıl kuruluyor →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

87710 Sep

1.2K

831

79311 Sep

807

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.57%10 Sep

1.03%

0.12%

0.38%11 Sep

0.50%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.68%.

What the audience does

Likes74.1%20 in total

Reposts18.5%5 in total

Bookmarks7.4%2 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Son gönderiler

Aynı büyüklükteki hesaplara karşı

Growth & engagement

Views per post

Engagement rate per post

What the audience does

Benzer hesaplar